Literature DB >> 35792997

Black and non-black population: investigation of the difference in butyrylcholinesterase activity in a healthy population in Salvador, Bahia.

Jucelino Nery da Conceição Filho1, Iris Campos Dos Santos2, Davi Pereira de Jesus Gonçalves3, Junia Raquel Dutra Ferreira3, Ana Leonor Pardo Campos Godoy3.   

Abstract

INTRODUCTION: Butyrylcholinesterase (BChE), an important biomarker of exposure to anticholinesterases, varies its activity according to the intensity and duration of exposure to these agents. Their normal values may vary in different populations. It is important to determine the reference values for the local population, mostly black/brown.
OBJECTIVE: The objective was to investigate the baseline values of BChE activity in a sample of the Salvador city population (Bahia, Brazil), evaluating the sociodemographic characteristics.
METHOD: A descriptive, quantitative study with a cross-sectional approach was carried out in 304 voluntary and healthy blood donors. BChE activity was determined using the integrated chemical system Dimension RxLMax and analyses of sociodemographic characteristics were performed.
RESULTS: For the 304 participants (18 to 67 years old), BChE activity values range were 7.4 to 19.8 U/mL (male) and 6.0 to 19.6 U/mL (female), without significant inter-racial differences (p = 0.986; Mann-Whitney). The participates were predominantly black (44.7%) and brown (40.5%), with higher levels of BchE activity in males (64.8%) (p-value = 0.01) than females (35.2%). There was no relationship between alcohol use and lower BChE activity (p = 0.725, Mann-Whitney). Women using hormonal contraceptives had a median activity 9.2% lower than the non-users.
CONCLUSION: Despite the high miscegenation and predominance of the black race in Salvador, contrary to what was expected, the sample did not show statistically significant intra-racial differences in BChE activity, being able to use the same reference values currently used, observing factors such as sex, use of contraceptives, and drinking alcohol.
© 2022. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Anticholinesterases; Black race; Butyrylcholinesterase; Enzyme; Healthy population

Year:  2022        PMID: 35792997     DOI: 10.1007/s11845-022-03087-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  18 in total

1.  Racial differences in the response to drugs--pointers to genetic differences.

Authors:  A J Wood
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

Review 2.  Why has butyrylcholinesterase been retained? Structural and functional diversification in a duplicated gene.

Authors:  Glynis Johnson; Samuel W Moore
Journal:  Neurochem Int       Date:  2012-06-28       Impact factor: 3.921

Review 3.  Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine.

Authors:  O Lockridge
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

Review 4.  A review of clinical applications and methods for cholinesterase.

Authors:  J Macqueen; D Plaut
Journal:  Am J Med Technol       Date:  1973-07

5.  Frequencies of atypical serum cholinesterase in a mixed population of northeastern Brazil.

Authors:  E A Chautard-Freire-Maia; R D Carvalho; M C da Silva; M G Souza; E S Azevedo
Journal:  Hum Hered       Date:  1984       Impact factor: 0.444

Review 6.  Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses.

Authors:  Oksana Lockridge
Journal:  Pharmacol Ther       Date:  2014-11-20       Impact factor: 12.310

7.  How personalized medicine became genetic, and racial: Werner Kalow and the formations of pharmacogenetics.

Authors:  David S Jones
Journal:  J Hist Med Allied Sci       Date:  2011-09-10       Impact factor: 2.088

Review 8.  Clinical and analytical considerations in the utilization of cholinesterase measurements.

Authors:  M J McQueen
Journal:  Clin Chim Acta       Date:  1995-06-15       Impact factor: 3.786

9.  Rapid identification of atypical variant of plasma butyrylcholinesterase by PCR.

Authors:  Franck Ceppa; Stephane Gidenne; Alain Benois; Eleonore Fontan; Pascal Burnat
Journal:  Clin Chem Lab Med       Date:  2002-08       Impact factor: 3.694

10.  Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes.

Authors:  André Brooking Negrão; Alexandre Costa Pereira; Camila Guindalini; Hadassa Campos Santos; Guilherme Peres Messas; Ronaldo Laranjeira; Homero Vallada
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.